首页 > 最新文献

Frontiers in Psychiatry最新文献

英文 中文
Characteristics of digital twins to visualize, monitor and predict outcomes on participation in meaningful activities. 数字双胞胎的特征,以可视化,监测和预测参与有意义的活动的结果。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-28 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1694966
Vera C Kaelin, Kaan Kilic, Anna Stigsdotter Neely, Hanna M Gavelin, Patrik Wennberg, Helena Lindgren

Introduction: This study aimed to explore the perspectives of occupational therapists and individuals with lived experience of mental health challenges regarding which aspects of participation in meaningful activities should be represented in digital twins, and how these aspects should be visualized.

Methods: We conducted a qualitative descriptive study involving 14 semi-structured interviews with occupational therapists and individuals with lived experience of mental health challenges. Interviews were transcribed verbatim and analyzed using inductive content analysis.

Results: Participants identified four main aspects to visualize in digital twins focusing on participation in meaningful activities: 1) the degree of being present and in-the-moment, 2) related or resulting experiences of being present and in-the-moment (including relaxation and calmness; fulfillment, purpose, joy, and playfulness; feeling vitalized; connection with oneself, others, and the world), 3) the energy needed and the energy gained from participation, and 4) the influence of the context. In addition, results revealed two main approaches for how these aspects should be visualized: 1) symbols and charts to visualize the now-situation, and 2) graphs for visualization over time.

Discussion and conclusion: Results identified four aspects of a participation in meaningful activities to be represented in digital twins. Those align with, and extend, existing literature on participation and recovery experiences. For the visualization of those aspects in digital twins, participants emphasized the importance of integrating both immediate feedback and longitudinal tracking of participation experiences.

本研究旨在探讨职业治疗师和有心理健康挑战生活经验的个体的观点,即数字双胞胎应该表现参与有意义活动的哪些方面,以及如何将这些方面可视化。方法:我们进行了一项定性描述性研究,包括对职业治疗师和有精神健康挑战生活经历的个人进行了14次半结构化访谈。访谈内容逐字记录,并采用归纳内容分析法进行分析。结果:参与者确定了数字孪生中关注参与有意义活动的四个主要方面:1)在场和当下的程度,2)在场和当下的相关或由此产生的体验(包括放松和冷静,满足感,目的,快乐和乐趣,感觉充满活力,以及对有意义活动的体验)。与自己,他人和世界的联系),3)所需的能量和从参与中获得的能量,以及4)环境的影响。此外,结果还揭示了如何将这些方面可视化的两种主要方法:1)符号和图表来可视化现在的情况,以及2)图形来可视化随着时间的推移。讨论和结论:结果确定了参与有意义的活动的四个方面,以数字双胞胎为代表。这些研究与现有的关于参与和康复经验的文献相一致,并加以扩展。对于数字孪生中这些方面的可视化,参与者强调了整合即时反馈和参与体验纵向跟踪的重要性。
{"title":"Characteristics of digital twins to visualize, monitor and predict outcomes on participation in meaningful activities.","authors":"Vera C Kaelin, Kaan Kilic, Anna Stigsdotter Neely, Hanna M Gavelin, Patrik Wennberg, Helena Lindgren","doi":"10.3389/fpsyt.2025.1694966","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1694966","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to explore the perspectives of occupational therapists and individuals with lived experience of mental health challenges regarding which aspects of participation in meaningful activities should be represented in digital twins, and how these aspects should be visualized.</p><p><strong>Methods: </strong>We conducted a qualitative descriptive study involving 14 semi-structured interviews with occupational therapists and individuals with lived experience of mental health challenges. Interviews were transcribed verbatim and analyzed using inductive content analysis.</p><p><strong>Results: </strong>Participants identified four main aspects to visualize in digital twins focusing on participation in meaningful activities: 1) the degree of being present and in-the-moment, 2) related or resulting experiences of being present and in-the-moment (including relaxation and calmness; fulfillment, purpose, joy, and playfulness; feeling vitalized; connection with oneself, others, and the world), 3) the energy needed and the energy gained from participation, and 4) the influence of the context. In addition, results revealed two main approaches for how these aspects should be visualized: 1) symbols and charts to visualize the now-situation, and 2) graphs for visualization over time.</p><p><strong>Discussion and conclusion: </strong>Results identified four aspects of a participation in meaningful activities to be represented in digital twins. Those align with, and extend, existing literature on participation and recovery experiences. For the visualization of those aspects in digital twins, participants emphasized the importance of integrating both immediate feedback and longitudinal tracking of participation experiences.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1694966"},"PeriodicalIF":3.2,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12891190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146178582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The imperative for culturally specific suicide prevention models beyond the Western gaze. 在西方的视线之外,有必要建立具有特定文化背景的自杀预防模式。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-28 eCollection Date: 2026-01-01 DOI: 10.3389/fpsyt.2026.1755211
Qian-Nan Ruan, Jing Qian, Xiu-Shuang Lin

Suicide remains a critical global public health challenge, with distinct prevalence patterns and risk factors observed across different cultural contexts. While evidence-based prevention strategies, such as Cognitive Behavioral Therapy (CBT), crisis hotlines, and gatekeeper training, have been developed predominantly in Western settings and have demonstrated efficacy, their application in non-Western populations faces unique cultural hurdles. This perspective article examines the limitations of applying individualistic suicide prevention models without sufficient adaptation to East Asian cultural contexts, which are often characterized by "shame-honor" dynamics and collectivist values. We acknowledge the significant contributions of existing Western frameworks but argue that a reliance on these models, if unexamined, may overlook specific barriers to help-seeking, such as the intense stigma associated with "loss of face" and the perception of mental distress as a burden to the family. By analyzing the "cultural mismatch" between the Western independent self and the East Asian interdependent self, this article calls for a paradigm shift toward "cultural grounding." We propose that the field must move beyond superficial adaptation toward the co-creation of interventions that integrate indigenous cultural narratives and social structures. This approach aims not to replace existing evidence-based practices but to enhance their relevance and accessibility, ensuring that suicide prevention strategies are truly responsive to the diverse realities of global populations.

自杀仍然是一项重大的全球公共卫生挑战,在不同的文化背景下观察到不同的流行模式和风险因素。虽然以证据为基础的预防策略,如认知行为疗法(CBT)、危机热线和看门人培训,主要在西方环境中发展并已证明有效,但它们在非西方人群中的应用面临着独特的文化障碍。这篇透视性的文章探讨了个人主义自杀预防模式在没有充分适应东亚文化背景下的局限性,东亚文化背景通常以“羞耻-荣誉”动力和集体主义价值观为特征。我们承认现有的西方框架的重要贡献,但我们认为,如果对这些模型的依赖未经检验,可能会忽视寻求帮助的具体障碍,例如与“丢脸”相关的强烈耻辱,以及将精神痛苦视为家庭负担的看法。通过分析西方独立自我和东亚相互依赖自我之间的“文化错位”,本文呼吁向“文化基础”的范式转变。我们建议,该领域必须超越表面的适应,走向整合土著文化叙事和社会结构的共同创造干预措施。这种方法的目的不是取代现有的循证做法,而是加强其相关性和可及性,确保自杀预防战略真正适应全球人口的多样化现实。
{"title":"The imperative for culturally specific suicide prevention models beyond the Western gaze.","authors":"Qian-Nan Ruan, Jing Qian, Xiu-Shuang Lin","doi":"10.3389/fpsyt.2026.1755211","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1755211","url":null,"abstract":"<p><p>Suicide remains a critical global public health challenge, with distinct prevalence patterns and risk factors observed across different cultural contexts. While evidence-based prevention strategies, such as Cognitive Behavioral Therapy (CBT), crisis hotlines, and gatekeeper training, have been developed predominantly in Western settings and have demonstrated efficacy, their application in non-Western populations faces unique cultural hurdles. This perspective article examines the limitations of applying individualistic suicide prevention models without sufficient adaptation to East Asian cultural contexts, which are often characterized by \"shame-honor\" dynamics and collectivist values. We acknowledge the significant contributions of existing Western frameworks but argue that a reliance on these models, if unexamined, may overlook specific barriers to help-seeking, such as the intense stigma associated with \"loss of face\" and the perception of mental distress as a burden to the family. By analyzing the \"cultural mismatch\" between the Western independent self and the East Asian interdependent self, this article calls for a paradigm shift toward \"cultural grounding.\" We propose that the field must move beyond superficial adaptation toward the co-creation of interventions that integrate indigenous cultural narratives and social structures. This approach aims not to replace existing evidence-based practices but to enhance their relevance and accessibility, ensuring that suicide prevention strategies are truly responsive to the diverse realities of global populations.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1755211"},"PeriodicalIF":3.2,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12891080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146179118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promethazine-induced neuroleptic malignant syndrome under general anesthesia: a case report. 全身麻醉下异丙嗪致抗精神病药恶性综合征1例。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-28 eCollection Date: 2026-01-01 DOI: 10.3389/fpsyt.2026.1700644
Peng Liu, Zhi-Min Liao

Background: Neuroleptic malignant syndrome (NMS) is a rare yet life-threatening disease that is often induced by antipsychotic medications.

Case presentation: In this study, we describe a case of a 13-year-old female who developed NMS following promethazine use during general anesthesia. This is expected to provide clinicians, particularly anesthesiologists, with crucial insights that will improve the perioperative identification and management of this condition. The patient manifested classic clinical features of NMS, including hyperpyrexia, autonomic dysfunction, and generalized rigidity. However, the patient's serum creatine phosphokinase (CPK) levels were within normal limits, demonstrating the heterogeneous presentation of the disorder. The main interventions included drugs targeting to achieve airway control, physical cooling, hemodynamic stabilization, and symptomatic management, which promoted the patient's gradual recovery.

Conclusion: This case illustrates that due to individual variations, even standard drug dosages may induce neuroleptic malignant syndrome (NMS). Notably, NMS lacks specific laboratory findings, and its diagnosis must rely on clinical symptoms to avoid delays in early identification and treatment.

背景:抗精神病药恶性综合征(NMS)是一种罕见但危及生命的疾病,通常由抗精神病药物引起。病例介绍:在本研究中,我们描述了一例13岁女性在全身麻醉期间使用异丙嗪后发生NMS的病例。这有望为临床医生,特别是麻醉师,提供关键的见解,以改善围手术期对这种情况的识别和管理。患者表现出NMS的典型临床特征,包括高热、自主神经功能障碍和全身僵直。然而,患者的血清肌酸磷酸激酶(CPK)水平在正常范围内,表明该疾病的异质性表现。主要干预措施包括靶向药物控制气道、物理降温、稳定血流动力学和对症处理,促进患者逐渐康复。结论:本病例提示,由于个体差异,即使是标准剂量的药物也可能诱发抗精神病药恶性综合征(NMS)。值得注意的是,NMS缺乏具体的实验室结果,其诊断必须依靠临床症状,以避免早期识别和治疗的延误。
{"title":"Promethazine-induced neuroleptic malignant syndrome under general anesthesia: a case report.","authors":"Peng Liu, Zhi-Min Liao","doi":"10.3389/fpsyt.2026.1700644","DOIUrl":"https://doi.org/10.3389/fpsyt.2026.1700644","url":null,"abstract":"<p><strong>Background: </strong>Neuroleptic malignant syndrome (NMS) is a rare yet life-threatening disease that is often induced by antipsychotic medications.</p><p><strong>Case presentation: </strong>In this study, we describe a case of a 13-year-old female who developed NMS following promethazine use during general anesthesia. This is expected to provide clinicians, particularly anesthesiologists, with crucial insights that will improve the perioperative identification and management of this condition. The patient manifested classic clinical features of NMS, including hyperpyrexia, autonomic dysfunction, and generalized rigidity. However, the patient's serum creatine phosphokinase (CPK) levels were within normal limits, demonstrating the heterogeneous presentation of the disorder. The main interventions included drugs targeting to achieve airway control, physical cooling, hemodynamic stabilization, and symptomatic management, which promoted the patient's gradual recovery.</p><p><strong>Conclusion: </strong>This case illustrates that due to individual variations, even standard drug dosages may induce neuroleptic malignant syndrome (NMS). Notably, NMS lacks specific laboratory findings, and its diagnosis must rely on clinical symptoms to avoid delays in early identification and treatment.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"17 ","pages":"1700644"},"PeriodicalIF":3.2,"publicationDate":"2026-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12891107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146179121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protocol for a cohort comparison treatment study evaluating the efficacy of a dimensional adaptation of GPM (GPM-extended) compared to a classic outpatient GPM treatment for patient fulfilling criteria for BPD: the EPSYLIA project. 一项队列比较治疗研究的方案,评估GPM的维度适应(GPM扩展)与经典门诊GPM治疗对满足BPD标准的患者的疗效:EPSYLIA项目。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1687987
Martin Blay, Inès Benmakhlouf, Marion Zenou, Mélissa Amate, Arjin Uludag-Martin, François Chevrier, Marie-Laure Pomey, Marie Brisebarre, Paul Lebourleux, Oyhana Lopepe, Julie Cacouault, Saioa Lagadec, Loïs Choi-Kain, Mario Speranza

Personality disorders (PD) are common and debilitating psychiatric conditions, often characterized by severe interpersonal and self-dysfunction. Borderline personality disorder (BPD) is the most studied PD, with treatments like Good Psychiatric Management (GPM) demonstrating effectiveness. To address the current state of the personality disorder field, where most evidence-based treatments have been developed using a categorical approach, while the most empirically supported approach is the dimensional one, we developed an adaptation of GPM (GPM-extended) integrating concepts of dimensional personality dysfunction into an established therapeutic framework. This prospective "here-there" study will compare GPM-extended with standard GPM in two outpatient facilities. This methodological choice is due to organizational and institutional limitations. Participants (≥18 years) meeting BPD criteria per the SCID-II will be included. The GPM-extended group incorporates a dimensional diagnostic framework focusing on three personality dilemmas (rejection/abandonment fears, self-esteem dysregulation, and perfection/control issues), with tailored psychoeducation and treatment priorities. The standard GPM group will follow the validated GPM protocol, emphasizing interpersonal hypersensitivity and standard psychoeducation. Both groups will receive weekly individual therapy and group interventions for one year. Between-group differences at 1-year follow-up will be assessed using multiple regression models adjusted for baseline scores. The primary outcome is the change in BPD symptom severity (ZAN-BPD). Secondary outcomes include personality functioning, traits, and various clinical dimensions such as impulsivity, emotional regulation, and social functioning. All patients having initiated the program and having initial data will be included in the analysis, with multiple imputations for missing data and sensitivity analyses planned. Altogether, this study seeks to evaluate the feasibility and efficacy of integrating dimensionality into GPM, offering a pragmatic pathway to improve PD treatment and bridging gaps between evidence-based conceptualizations and treatments of PD.

Clinical trial registration: ClinicalTrials.gov, identifier NCT06913738.

人格障碍(PD)是一种常见的使人衰弱的精神疾病,通常以严重的人际关系和自我功能障碍为特征。边缘型人格障碍(BPD)是研究最多的PD,良好的精神病学管理(GPM)等治疗方法显示出有效性。为了解决人格障碍领域的现状,大多数基于证据的治疗方法都是使用分类方法开发的,而最受经验支持的方法是维度方法,我们开发了一种适应性的GPM (GPM扩展),将维度人格功能障碍的概念整合到一个既定的治疗框架中。这项前瞻性的“这里-那里”研究将比较两家门诊机构的GPM扩展和标准GPM。这种方法的选择是由于组织和制度的限制。符合SCID-II BPD标准的参与者(≥18岁)将被纳入。gpm扩展组结合了一个维度诊断框架,重点关注三种人格困境(拒绝/遗弃恐惧,自尊失调和完美/控制问题),并提供量身定制的心理教育和治疗重点。标准GPM组将遵循经过验证的GPM方案,强调人际超敏反应和标准心理教育。两组都将接受每周一次的个人治疗和团体干预,为期一年。1年随访时的组间差异将采用基线评分调整后的多元回归模型进行评估。主要结局是BPD症状严重程度的改变(ZAN-BPD)。次要结果包括人格功能、特征和各种临床维度,如冲动、情绪调节和社会功能。所有已启动该计划并拥有初始数据的患者将纳入分析,并计划对缺失数据进行多重输入和敏感性分析。总之,本研究旨在评估将维度纳入GPM的可行性和有效性,为改善PD治疗提供一条务实的途径,并弥合基于证据的PD概念化与治疗之间的差距。临床试验注册:ClinicalTrials.gov,标识符NCT06913738。
{"title":"Protocol for a cohort comparison treatment study evaluating the efficacy of a dimensional adaptation of GPM (GPM-extended) compared to a classic outpatient GPM treatment for patient fulfilling criteria for BPD: the EPSYLIA project.","authors":"Martin Blay, Inès Benmakhlouf, Marion Zenou, Mélissa Amate, Arjin Uludag-Martin, François Chevrier, Marie-Laure Pomey, Marie Brisebarre, Paul Lebourleux, Oyhana Lopepe, Julie Cacouault, Saioa Lagadec, Loïs Choi-Kain, Mario Speranza","doi":"10.3389/fpsyt.2025.1687987","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1687987","url":null,"abstract":"<p><p>Personality disorders (PD) are common and debilitating psychiatric conditions, often characterized by severe interpersonal and self-dysfunction. Borderline personality disorder (BPD) is the most studied PD, with treatments like Good Psychiatric Management (GPM) demonstrating effectiveness. To address the current state of the personality disorder field, where most evidence-based treatments have been developed using a categorical approach, while the most empirically supported approach is the dimensional one, we developed an adaptation of GPM (GPM-extended) integrating concepts of dimensional personality dysfunction into an established therapeutic framework. This prospective \"here-there\" study will compare GPM-extended with standard GPM in two outpatient facilities. This methodological choice is due to organizational and institutional limitations. Participants (≥18 years) meeting BPD criteria per the SCID-II will be included. The GPM-extended group incorporates a dimensional diagnostic framework focusing on three personality dilemmas (rejection/abandonment fears, self-esteem dysregulation, and perfection/control issues), with tailored psychoeducation and treatment priorities. The standard GPM group will follow the validated GPM protocol, emphasizing interpersonal hypersensitivity and standard psychoeducation. Both groups will receive weekly individual therapy and group interventions for one year. Between-group differences at 1-year follow-up will be assessed using multiple regression models adjusted for baseline scores. The primary outcome is the change in BPD symptom severity (ZAN-BPD). Secondary outcomes include personality functioning, traits, and various clinical dimensions such as impulsivity, emotional regulation, and social functioning. All patients having initiated the program and having initial data will be included in the analysis, with multiple imputations for missing data and sensitivity analyses planned. Altogether, this study seeks to evaluate the feasibility and efficacy of integrating dimensionality into GPM, offering a pragmatic pathway to improve PD treatment and bridging gaps between evidence-based conceptualizations and treatments of PD.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov, identifier NCT06913738.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1687987"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain causality alterations in major depressive disorder treatment. 重度抑郁症治疗中的脑因果关系改变。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1718216
Madhurima Bhattacharjee, Ioannis Vlachos, Aditi Kathpalia, Jaroslav Hlinka, Martin Brunovský, Martin Bareš, Milan Paluš
<p><strong>Introduction: </strong>Major depressive disorder (MDD) remains a leading cause of disability worldwide, with limited objective biomarkers to guide treatment selection and monitor early therapeutic effects. This study examines whether pharmacological and neurostimulation treatments produce distinct alterations in directional brain connectivity patterns within the first week of treatment and whether baseline connectivity patterns differ between treatment responders and nonresponders assessed at 4-6 weeks.</p><p><strong>Methods: </strong>We perform an information theory-based causality analysis on instantaneous phase time series derived from electroencephalography recordings of 176 MDD patients. Patients received either pharmacological treatment or neurostimulation and were recorded at baseline (visit 1) and one week post-treatment initiation (visit 2). We quantified directional information flow across 19 EEG channels in five frequency bands ( <math><mi>δ</mi></math> : 1.5-3.5Hz, <math><mi>θ</mi></math> : 4-8Hz, <math><mi>α</mi></math> : 8-12Hz, <math> <mrow><msub><mi>β</mi> <mn>1</mn></msub> </mrow> </math> : 12.5-17.5Hz, <math> <mrow><msub><mi>β</mi> <mn>2</mn></msub> </mrow> </math> : 18-25.5Hz) using global FLOW metrics and local INFLOW/OUTFLOW metrics per channel.</p><p><strong>Results: </strong>Treatment modalities produced distinct frequency-specific alterations in brain causality. Pharmacological treatment significantly increased global and local information transmission in the <i>β</i> <sub>2</sub> band from visit 1 to visit 2, with widespread effects across brain regions and larger increases in right hemisphere inflow. Neurostimulation treatment increased information flow primarily in the <i>δ</i> band, with the strongest effects originating from left hemisphere to the whole brain. At baseline, pharmacological nonresponders exhibited significantly higher <i>α</i> band information flow than responders, particularly for right-to-left hemisphere transmission and bilateral inflow. No significant baseline differences emerged between neurostimulation responders and nonresponders, though large effect sizes in <i>δ</i> band metrics suggest findings may achieve significance with larger samples.</p><p><strong>Discussion: </strong>Early-phase directional brain connectivity analysis reveals that pharmacological and neurostimulation treatments engage distinct neural oscillatory mechanisms within the first week. Elevated baseline right-dominant <i>α</i>-band causal transmission identifies patients unlikely to respond to pharmacological treatment, enabling alternative interventions before weeks of ineffective therapy. These phase-based causality metrics offer promising biomarkers for early treatment stratification and monitoring. The ability to distinguish treatment responders from nonresponders at baseline and detect treatment-specific changes within one week, before clinical response manifestation, suggests these causality measures capture e
重度抑郁障碍(MDD)仍然是世界范围内致残的主要原因,指导治疗选择和监测早期治疗效果的客观生物标志物有限。本研究考察了药物和神经刺激治疗是否在治疗的第一周内产生定向脑连接模式的明显改变,以及4-6周时评估的治疗应答者和无应答者之间的基线连接模式是否不同。方法:对176例重度抑郁症患者的脑电图记录进行了基于信息理论的瞬时相位时间序列因果分析。患者接受药物治疗或神经刺激,并在基线(访问1)和治疗开始后一周(访问2)进行记录。我们使用全局flow指标和每个通道的局部流入/流出指标,量化了5个频段(δ: 1.5-3.5Hz, θ: 4-8Hz, α: 8-12Hz, β 1:5 -17.5 hz, β 2:18 -25.5 hz)的19个EEG通道的定向信息流。结果:治疗方式在脑因果关系中产生了明显的频率特异性改变。药物治疗显著增加了从第一次访问到第二次访问的β 2波段的整体和局部信息传递,在整个大脑区域具有广泛的影响,右半球流入增加更大。神经刺激治疗主要增加δ波段的信息流,从左脑到全脑的影响最强。在基线时,药物无反应者表现出明显高于反应者的α带信息流,特别是在右至左半球传递和双侧流入方面。在神经刺激反应者和无反应者之间没有明显的基线差异,尽管δ波段度量的大效应量表明研究结果可能在更大的样本中具有显著性。讨论:早期定向脑连接分析表明,药物和神经刺激治疗在第一周内涉及不同的神经振荡机制。升高的基线右侧显性α带因果传递识别出不太可能对药物治疗产生反应的患者,从而在治疗无效前进行替代干预。这些基于阶段的因果关系指标为早期治疗分层和监测提供了有希望的生物标志物。在基线时区分治疗反应者和无反应者的能力,以及在临床反应出现之前一周内检测治疗特异性变化的能力,表明这些因果关系测量可以捕获早期机制改变,从而及时告知治疗优化决策。(EUDRACT号2005-000826-22和2015-001639-19,通过www.clinicaltrialsregister.eu注册)。
{"title":"Brain causality alterations in major depressive disorder treatment.","authors":"Madhurima Bhattacharjee, Ioannis Vlachos, Aditi Kathpalia, Jaroslav Hlinka, Martin Brunovský, Martin Bareš, Milan Paluš","doi":"10.3389/fpsyt.2025.1718216","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1718216","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Major depressive disorder (MDD) remains a leading cause of disability worldwide, with limited objective biomarkers to guide treatment selection and monitor early therapeutic effects. This study examines whether pharmacological and neurostimulation treatments produce distinct alterations in directional brain connectivity patterns within the first week of treatment and whether baseline connectivity patterns differ between treatment responders and nonresponders assessed at 4-6 weeks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We perform an information theory-based causality analysis on instantaneous phase time series derived from electroencephalography recordings of 176 MDD patients. Patients received either pharmacological treatment or neurostimulation and were recorded at baseline (visit 1) and one week post-treatment initiation (visit 2). We quantified directional information flow across 19 EEG channels in five frequency bands ( &lt;math&gt;&lt;mi&gt;δ&lt;/mi&gt;&lt;/math&gt; : 1.5-3.5Hz, &lt;math&gt;&lt;mi&gt;θ&lt;/mi&gt;&lt;/math&gt; : 4-8Hz, &lt;math&gt;&lt;mi&gt;α&lt;/mi&gt;&lt;/math&gt; : 8-12Hz, &lt;math&gt; &lt;mrow&gt;&lt;msub&gt;&lt;mi&gt;β&lt;/mi&gt; &lt;mn&gt;1&lt;/mn&gt;&lt;/msub&gt; &lt;/mrow&gt; &lt;/math&gt; : 12.5-17.5Hz, &lt;math&gt; &lt;mrow&gt;&lt;msub&gt;&lt;mi&gt;β&lt;/mi&gt; &lt;mn&gt;2&lt;/mn&gt;&lt;/msub&gt; &lt;/mrow&gt; &lt;/math&gt; : 18-25.5Hz) using global FLOW metrics and local INFLOW/OUTFLOW metrics per channel.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Treatment modalities produced distinct frequency-specific alterations in brain causality. Pharmacological treatment significantly increased global and local information transmission in the &lt;i&gt;β&lt;/i&gt; &lt;sub&gt;2&lt;/sub&gt; band from visit 1 to visit 2, with widespread effects across brain regions and larger increases in right hemisphere inflow. Neurostimulation treatment increased information flow primarily in the &lt;i&gt;δ&lt;/i&gt; band, with the strongest effects originating from left hemisphere to the whole brain. At baseline, pharmacological nonresponders exhibited significantly higher &lt;i&gt;α&lt;/i&gt; band information flow than responders, particularly for right-to-left hemisphere transmission and bilateral inflow. No significant baseline differences emerged between neurostimulation responders and nonresponders, though large effect sizes in &lt;i&gt;δ&lt;/i&gt; band metrics suggest findings may achieve significance with larger samples.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;Early-phase directional brain connectivity analysis reveals that pharmacological and neurostimulation treatments engage distinct neural oscillatory mechanisms within the first week. Elevated baseline right-dominant &lt;i&gt;α&lt;/i&gt;-band causal transmission identifies patients unlikely to respond to pharmacological treatment, enabling alternative interventions before weeks of ineffective therapy. These phase-based causality metrics offer promising biomarkers for early treatment stratification and monitoring. The ability to distinguish treatment responders from nonresponders at baseline and detect treatment-specific changes within one week, before clinical response manifestation, suggests these causality measures capture e","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1718216"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146164987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric outcomes after primary and secondary earthquake exposure: effects of loss, media, and treatment. 原发性和继发性地震暴露后的精神结果:损失、媒介和治疗的影响。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1715590
Hüseyin Ozan Torun, Burak Akdöner, Talat Sarıkavak, Umut Kirli

Introduction: Earthquakes can cause substantial psychiatric morbidity including Post-Traumatic Stress Disorder (PTSD). While direct exposure effects are well known less is understood about relapse after indirect exposure. Following the 2023 Kahramanmaraş earthquakes clinicians observed renewed distress among survivors of the 2020 Aegean Sea earthquake. Understanding how media exposure individual factors contribute to symptom reactivation is important for post-disaster care. This study investigated factors linked to PTSD symptom relapse after repeated disaster exposure.

Method: This prospective quantitative study (February 2023-February 2024) recruited patients from a psychiatry outpatient clinic following the Kahramanmaraş earthquakes. Individuals with earthquake-related complaints who had also experienced the 2020 Aegean Sea earthquake were enrolled. Post-traumatic stress symptoms were assessed using the Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) at baseline and at 1, 3, 6, 9, and 12 months. Resilience was measured using the Resilience Scale for Adults (RSA) at baseline. Sociodemographic and clinical variables, including prior psychiatric treatment and media exposure type, were recorded. Multivariate analysis of variance was used to examine longitudinal symptom trajectories and predictors.

Results: The study included 87 participants (mean age = 48.8 ± 12.5yrs), the majority were female (85%). Following the Aegean Sea earthquake, 45% of participants received psychiatric treatment, with loss experience being the only significant predictor of treatment seeking (χ² = 14.90, p <.001). After the Kahramanmaraş earthquakes, 74.7% received psychiatric treatment. A significant effect of time on PCL-5 symptom severity across the 12-month follow-up (Pillais Trace = .40, F = 7.32, p <.001). Age and resilience were independently associated with PTSD severity, with resilience showing the strongest effect (F = 40.24, p <.001). Higher PCL-5 scores among those primarily exposed to traditional media (F = 5.11, p = .027), symptom trajectories did not differ over time.

Conclusion: This study shows that indirect exposure to large-scale disasters can shape symptom trajectories in previously affected individuals. Resilience served as a protective factor, while prior treatment indicated both vulnerability and adaptive potential. Media exposure type also influenced symptom severity. These results highlight the value of assessing resilience, treatment history, and media use in trauma-informed care after repeated disaster exposure.

地震可导致大量精神疾病,包括创伤后应激障碍(PTSD)。虽然直接暴露的影响众所周知,但对间接暴露后复发的了解较少。在2023年kahramanmaraki地震之后,临床医生观察到2020年爱琴海地震的幸存者再次感到痛苦。了解媒体暴露的个体因素如何促进症状再激活对灾后护理很重要。本研究调查了多次灾难暴露后PTSD症状复发的相关因素。方法:这项前瞻性定量研究(2023年2月- 2024年2月)从kahramanmaraku地震后的精神病学门诊招募患者。有地震相关投诉的个人也经历了2020年爱琴海地震。在基线和1、3、6、9和12个月时,使用DSM-5 (PCL-5)创伤后应激障碍检查表评估创伤后应激症状。在基线时使用成人弹性量表(RSA)测量弹性。记录社会人口统计学和临床变量,包括先前的精神治疗和媒体接触类型。多变量方差分析用于检验纵向症状轨迹和预测因子。结果:共纳入87例患者,平均年龄48.8±12.5岁,以女性为主(85%)。爱琴海地震后,45%的参与者接受了精神治疗,损失经历是寻求治疗的唯一显著预测因素(χ²= 14.90,p)。结论:本研究表明,间接暴露于大规模灾害可以塑造先前受影响个体的症状轨迹。恢复力是保护因素,而先前的治疗表明脆弱性和适应潜力。媒介暴露类型对症状严重程度也有影响。这些结果强调了评估复原力、治疗史和媒体使用在反复灾难暴露后创伤知情护理中的价值。
{"title":"Psychiatric outcomes after primary and secondary earthquake exposure: effects of loss, media, and treatment.","authors":"Hüseyin Ozan Torun, Burak Akdöner, Talat Sarıkavak, Umut Kirli","doi":"10.3389/fpsyt.2025.1715590","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1715590","url":null,"abstract":"<p><strong>Introduction: </strong>Earthquakes can cause substantial psychiatric morbidity including Post-Traumatic Stress Disorder (PTSD). While direct exposure effects are well known less is understood about relapse after indirect exposure. Following the 2023 Kahramanmaraş earthquakes clinicians observed renewed distress among survivors of the 2020 Aegean Sea earthquake. Understanding how media exposure individual factors contribute to symptom reactivation is important for post-disaster care. This study investigated factors linked to PTSD symptom relapse after repeated disaster exposure.</p><p><strong>Method: </strong>This prospective quantitative study (February 2023-February 2024) recruited patients from a psychiatry outpatient clinic following the Kahramanmaraş earthquakes. Individuals with earthquake-related complaints who had also experienced the 2020 Aegean Sea earthquake were enrolled. Post-traumatic stress symptoms were assessed using the Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) at baseline and at 1, 3, 6, 9, and 12 months. Resilience was measured using the Resilience Scale for Adults (RSA) at baseline. Sociodemographic and clinical variables, including prior psychiatric treatment and media exposure type, were recorded. Multivariate analysis of variance was used to examine longitudinal symptom trajectories and predictors.</p><p><strong>Results: </strong>The study included 87 participants (mean age = 48.8 ± 12.5yrs), the majority were female (85%). Following the Aegean Sea earthquake, 45% of participants received psychiatric treatment, with loss experience being the only significant predictor of treatment seeking (χ² = 14.90, p <.001). After the Kahramanmaraş earthquakes, 74.7% received psychiatric treatment. A significant effect of time on PCL-5 symptom severity across the 12-month follow-up (Pillais Trace = .40, F = 7.32, p <.001). Age and resilience were independently associated with PTSD severity, with resilience showing the strongest effect (F = 40.24, p <.001). Higher PCL-5 scores among those primarily exposed to traditional media (F = 5.11, p = .027), symptom trajectories did not differ over time.</p><p><strong>Conclusion: </strong>This study shows that indirect exposure to large-scale disasters can shape symptom trajectories in previously affected individuals. Resilience served as a protective factor, while prior treatment indicated both vulnerability and adaptive potential. Media exposure type also influenced symptom severity. These results highlight the value of assessing resilience, treatment history, and media use in trauma-informed care after repeated disaster exposure.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1715590"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Embracing the psychological complexity of tinnitus-correlated distress: from descriptive nosology to person-centred explanatory models. 拥抱耳鸣相关痛苦的心理复杂性:从描述性分类学到以人为中心的解释模型。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1724030
Benjamin Boecking, Kurt Steinmetzger, Matthias Rose, Petra Brueggemann, Birgit Mazurek

Chronic tinnitus presents a psychosomatic paradox: while the perceptual characteristics of the sound are often similar across individuals and typically linked to hearing loss, the distress it evokes differs substantially. This distress predicts the experiential quality, persistence, and chronification of tinnitus perception, thereby shaping what is recognised as chronic tinnitus or tinnitus disorder in clinical practice. In conceptualizing distress, two interconnected processes of medicalisation can be observed: first, the framing of distressing tinnitus as a medical disorder in its own right; and second, the framing of distress itself as a psychiatric "comorbidity." However, the dominant medical-descriptive frameworks in psychiatry that underpin these practices rely on atheoretical, categorical systems to classify emotional distress. These systems have well-documented limits in reliability, validity, and clinical utility and tend to privilege biomedical explanations over psychosocial context. At this juncture, the current paper examines three conceptual approaches to distress: (1) medical-nomothetic-descriptive, (2) psychological-nomothetic-descriptive, and (3) psychological-idiographic-descriptive - which becomes explanatory upon considering individuals' life contexts, meaning-based appraisals, and symptom functions. For both clinical and research practice in chronic tinnitus, we argue for a shift towards psychological-explanatory-idiographic models that account for person-specific interactions of vulnerability, stress , emotions, and coping (VSEC), linked through personal meaning. This aligns with a broader momentum towards idiographic, process-based therapies as the future of psychological intervention. Although meaning-centred formulations challenge nomothetic research methodologies, they offer clearer clinical reasoning and help avoid unhelpful medicalisation beyond somatic factors which contribute to initial symptom onset.

慢性耳鸣表现出一种身心矛盾:虽然声音的感知特征在个体之间通常是相似的,并且通常与听力损失有关,但它引起的痛苦却有很大不同。这种痛苦预示着耳鸣感知的体验质量、持久性和慢性化,从而形成了临床实践中公认的慢性耳鸣或耳鸣障碍。在概念化痛苦时,可以观察到两个相互关联的医疗化过程:首先,将痛苦耳鸣视为自身的医学疾病;第二,将痛苦本身定义为精神“共病”。然而,精神病学中支撑这些实践的主流医学描述框架依赖于一种理论的、分类的系统来对情绪困扰进行分类。这些系统在可靠性、有效性和临床应用方面有充分的限制,并且倾向于将生物医学解释置于社会心理背景之上。在这个关键时刻,当前的论文研究了三种概念性的痛苦方法:(1)医学-名称-描述,(2)心理-名称-描述,和(3)心理-具体-描述-考虑到个人的生活背景,基于意义的评估和症状功能,这变得解释。对于慢性耳鸣的临床和研究实践,我们主张转向心理-解释-具体模型,该模型解释了个体特异性的脆弱性,压力,情绪和应对(VSEC)的相互作用,通过个人意义联系起来。这与一种更广泛的趋势相一致,即以具体的、基于过程的治疗作为心理干预的未来。尽管以意义为中心的配方挑战了本体研究方法,但它们提供了更清晰的临床推理,并有助于避免超出导致初始症状发作的躯体因素的无用医学化。
{"title":"Embracing the psychological complexity of tinnitus-correlated distress: from descriptive nosology to person-centred explanatory models.","authors":"Benjamin Boecking, Kurt Steinmetzger, Matthias Rose, Petra Brueggemann, Birgit Mazurek","doi":"10.3389/fpsyt.2025.1724030","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1724030","url":null,"abstract":"<p><p>Chronic tinnitus presents a psychosomatic paradox: while the perceptual characteristics of the sound are often similar across individuals and typically linked to hearing loss, the distress it evokes differs substantially. This distress predicts the experiential quality, persistence, and chronification of tinnitus perception, thereby shaping what is recognised as chronic tinnitus or tinnitus disorder in clinical practice. In conceptualizing distress, two interconnected processes of medicalisation can be observed: first, the framing of distressing tinnitus as a medical disorder in its own right; and second, the framing of distress itself as a psychiatric \"comorbidity.\" However, the dominant medical-descriptive frameworks in psychiatry that underpin these practices rely on atheoretical, categorical systems to classify emotional distress. These systems have well-documented limits in reliability, validity, and clinical utility and tend to privilege biomedical explanations over psychosocial context. At this juncture, the current paper examines three conceptual approaches to distress: (1) medical-nomothetic-descriptive, (2) psychological-nomothetic-descriptive, and (3) psychological-idiographic-descriptive - which becomes explanatory upon considering individuals' life contexts, meaning-based appraisals, and symptom functions. For both clinical and research practice in chronic tinnitus, we argue for a shift towards psychological-explanatory-idiographic models that account for person-specific interactions of vulnerability, stress , emotions, and coping (VSEC), linked through personal meaning. This aligns with a broader momentum towards idiographic, process-based therapies as the future of psychological intervention. Although meaning-centred formulations challenge nomothetic research methodologies, they offer clearer clinical reasoning and help avoid unhelpful medicalisation beyond somatic factors which contribute to initial symptom onset.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1724030"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888216/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global burden of schizophrenia in 204 countries and regions from 1990 to 2021 and machine learning-based projections to 2036: an analysis of the 2021 global burden of disease study. 从1990年到2021年204个国家和地区的精神分裂症全球负担以及到2036年基于机器学习的预测:2021年全球疾病负担研究分析
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1684168
Zhenyu Feng, Xuesong Shan, Baowen Fan, Ling Yang, Fang Gong

Background: Schizophrenia is a chronic mental disorder and one of the greatest contributors to the global burden of disease. This study aimed to analyze the global burden of schizophrenia from 1990 to 2021 and predict its future trends.

Methods: Data from the 2021 Global Burden of Disease (GBD) study were used. Trend analysis was conducted using the estimated annual percentage change (EAPC), Joinpoint regression, and age-period-cohort analysis. Future projections were generated using the Bayesian age-period-cohort (BAPC) model and time-series machine learning (ML) models.

Results: 2021, schizophrenia was estimated to affect approximately 23.6 million individuals worldwide, with 1.22 million new cases reported globally. This disorder accounted for 14.82 million disability-adjusted life years (DALYs) lost. From 1990 to 2021, the age-standardized incidence rate (ASIR) exhibited a declining trend with an EAPC of -0.04% (95% UI: -0.04% to -0.03%), whereas the age-standardized prevalence rate (ASPR) and age-standardized disability-adjusted life years rate (ASDR) demonstrated upward trajectories, showing EAPCs of 0.03% (95% UI: 0.02% to 0.04%) and 0.04%(95% UI: -0.03% to -0.05%), respectively. The peak age of onset was 20-24 years, while prevalence and DALYs peaked at 30-34 years, with males exhibiting a higher disease burden. The ARIMA, PROPHET, and Elastic Net models demonstrated superior predictive performance for forecasting future trends of global ASIR, ASPR, and ASDR. Projections suggest a continued global decline in ASIR, while ASPR and ASDR are expected to rise in the future.

Conclusion: Our research indicates that the ASIR, ASPR, and ASDR of schizophrenia exhibit significant correlations with gender, socio-demographic index (SDI) and regions. From 2022 to 2036, while the global ASIR of schizophrenia may decline, both the ASPR and ASDR are projected to rise. The escalating disease burden of schizophrenia poses a significant challenge for countries across all development levels.

背景:精神分裂症是一种慢性精神障碍,也是造成全球疾病负担的最大因素之一。本研究旨在分析1990年至2021年精神分裂症的全球负担,并预测其未来趋势。方法:使用2021年全球疾病负担(GBD)研究的数据。趋势分析采用估计年百分比变化(EAPC), Joinpoint回归和年龄-时期-队列分析。使用贝叶斯年龄-时期-队列(BAPC)模型和时间序列机器学习(ML)模型生成未来预测。结果:2021年,精神分裂症估计影响全球约2360万人,全球报告了122万例新病例。这种疾病造成1482万残疾调整生命年(DALYs)的损失。1990 - 2021年,年龄标准化发病率(ASIR)呈下降趋势,EAPC为-0.04% (95% UI: -0.04% ~ -0.03%),而年龄标准化患病率(ASPR)和年龄标准化残疾调整生命年率(ASDR)呈上升趋势,EAPC分别为0.03% (95% UI: 0.02% ~ 0.04%)和0.04%(95% UI: -0.03% ~ -0.05%)。发病高峰年龄为20-24岁,患病率和伤残调整生命年高峰为30-34岁,男性表现出更高的疾病负担。ARIMA、PROPHET和Elastic Net模型在预测全球ASIR、ASPR和ASDR的未来趋势方面表现出卓越的预测性能。预测表明,全球ASIR将继续下降,而ASPR和ASDR预计将在未来上升。结论:精神分裂症患者的ASIR、ASPR和ASDR与性别、社会人口指数(SDI)和地区存在显著相关。从2022年到2036年,虽然精神分裂症的全球ASIR可能会下降,但预计ASPR和ASDR都将上升。精神分裂症不断加重的疾病负担对所有发展水平的国家构成了重大挑战。
{"title":"Global burden of schizophrenia in 204 countries and regions from 1990 to 2021 and machine learning-based projections to 2036: an analysis of the 2021 global burden of disease study.","authors":"Zhenyu Feng, Xuesong Shan, Baowen Fan, Ling Yang, Fang Gong","doi":"10.3389/fpsyt.2025.1684168","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1684168","url":null,"abstract":"<p><strong>Background: </strong>Schizophrenia is a chronic mental disorder and one of the greatest contributors to the global burden of disease. This study aimed to analyze the global burden of schizophrenia from 1990 to 2021 and predict its future trends.</p><p><strong>Methods: </strong>Data from the 2021 Global Burden of Disease (GBD) study were used. Trend analysis was conducted using the estimated annual percentage change (EAPC), Joinpoint regression, and age-period-cohort analysis. Future projections were generated using the Bayesian age-period-cohort (BAPC) model and time-series machine learning (ML) models.</p><p><strong>Results: </strong>2021, schizophrenia was estimated to affect approximately 23.6 million individuals worldwide, with 1.22 million new cases reported globally. This disorder accounted for 14.82 million disability-adjusted life years (DALYs) lost. From 1990 to 2021, the age-standardized incidence rate (ASIR) exhibited a declining trend with an EAPC of -0.04% (95% UI: -0.04% to -0.03%), whereas the age-standardized prevalence rate (ASPR) and age-standardized disability-adjusted life years rate (ASDR) demonstrated upward trajectories, showing EAPCs of 0.03% (95% UI: 0.02% to 0.04%) and 0.04%(95% UI: -0.03% to -0.05%), respectively. The peak age of onset was 20-24 years, while prevalence and DALYs peaked at 30-34 years, with males exhibiting a higher disease burden. The ARIMA, PROPHET, and Elastic Net models demonstrated superior predictive performance for forecasting future trends of global ASIR, ASPR, and ASDR. Projections suggest a continued global decline in ASIR, while ASPR and ASDR are expected to rise in the future.</p><p><strong>Conclusion: </strong>Our research indicates that the ASIR, ASPR, and ASDR of schizophrenia exhibit significant correlations with gender, socio-demographic index (SDI) and regions. From 2022 to 2036, while the global ASIR of schizophrenia may decline, both the ASPR and ASDR are projected to rise. The escalating disease burden of schizophrenia poses a significant challenge for countries across all development levels.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1684168"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12887702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A unique case of food restriction and OCD diagnosed as PANDAS and a review of the literature. 饮食限制和强迫症诊断为熊猫的独特案例和文献综述。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1704296
Amal Y Kentab, Rolan Bassraway

Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) is recognized as a significant causative element in the emergence of childhood-onset obsessive-compulsive disorder (OCD) and movement disorders, including tic disorders, and choreiform movement. It is associated with various behavioral and psychiatric manifestations in children, such as separation anxiety disorder, body dysmorphic disorder, attention deficit hyperactivity disorder, and eating disorders. We describe a unique case of progressive weight loss in a previously healthy 13-year-old child who had a sudden and dramatic onset of refusal to eat, induction of vomiting, emotional liability, anxiety disorder, and OCD over 6 months following fever and pharyngitis. His workup showed an elevation of antistreptolysin O (ASO) titer with a negative throat swab. PANDAS was considered. His irritability improved after a course of antibiotics, and abatement of all symptoms and progressive weight gain occurred after a course of intravenous immunoglobulin (IVIG) followed by monthly benzathine penicillin injections. This report could help to increase awareness among physicians, highlight the importance of early diagnosis, and promote treatment of PANDAS among patients who present with a combination of eating disorders and OCD.

与链球菌感染相关的儿童自身免疫性神经精神障碍(PANDAS)被认为是儿童期发病的强迫症(OCD)和运动障碍(包括抽动障碍和舞蹈样运动)出现的重要致病因素。它与儿童的各种行为和精神表现有关,如分离焦虑障碍、身体畸形障碍、注意缺陷多动障碍和饮食障碍。我们描述了一个独特的情况下,进行性体重减轻在一个健康的13岁的孩子突然和戏剧性的开始拒绝进食,诱导呕吐,情绪不安,焦虑障碍,强迫症在发烧和咽炎后6个多月。检查结果显示抗链球菌溶血素O (ASO)滴度升高,咽拭子阴性。考虑了PANDAS。在一个疗程的抗生素治疗后,他的易怒症状得到改善,在一个疗程的静脉注射免疫球蛋白(IVIG)和每月注射苄星青霉素后,所有症状减轻,体重逐渐增加。该报告有助于提高医生的认识,强调早期诊断的重要性,并促进对饮食失调和强迫症合并患者的PANDAS治疗。
{"title":"A unique case of food restriction and OCD diagnosed as PANDAS and a review of the literature.","authors":"Amal Y Kentab, Rolan Bassraway","doi":"10.3389/fpsyt.2025.1704296","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1704296","url":null,"abstract":"<p><p>Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS) is recognized as a significant causative element in the emergence of childhood-onset obsessive-compulsive disorder (OCD) and movement disorders, including tic disorders, and choreiform movement. It is associated with various behavioral and psychiatric manifestations in children, such as separation anxiety disorder, body dysmorphic disorder, attention deficit hyperactivity disorder, and eating disorders. We describe a unique case of progressive weight loss in a previously healthy 13-year-old child who had a sudden and dramatic onset of refusal to eat, induction of vomiting, emotional liability, anxiety disorder, and OCD over 6 months following fever and pharyngitis. His workup showed an elevation of antistreptolysin O (ASO) titer with a negative throat swab. PANDAS was considered. His irritability improved after a course of antibiotics, and abatement of all symptoms and progressive weight gain occurred after a course of intravenous immunoglobulin (IVIG) followed by monthly benzathine penicillin injections. This report could help to increase awareness among physicians, highlight the importance of early diagnosis, and promote treatment of PANDAS among patients who present with a combination of eating disorders and OCD.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1704296"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12888229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodological insights from the inside: developing autistic-friendly interviewing in a group interview space. 来自内部的方法论见解:在小组面试空间中发展自闭症友好型面试。
IF 3.2 3区 医学 Q2 PSYCHIATRY Pub Date : 2026-01-27 eCollection Date: 2025-01-01 DOI: 10.3389/fpsyt.2025.1659580
Åsa Hedlund, Maria Eriksson Wester, Pia Edenvik, Cecilia Ingard, Kajsa Isakson, Lisa Kron Sabel, Danielle Uneus, Hanna Bertilsdotter Rosqvist

Background: A neurodiversity-informed approach recognizes the perspectives and experiences of autistic people from an insider perspective, yet little attention has been given to adapting qualitative methods to account for the impact of cognition, sociality, and communication style of both interviewers and participants. The aim of this paper was to contribute to the development of autistic-friendly interviewing in a group interview space.

Methods: The paper is a collective reflexive pilot study, exploring experiences of autistic interviewer and autistic participants in group interviews. The method followed five steps, from deciding what type of interview questions to use to test them in the group interviews. An autistic interviewer conducted three group interviews, each with two to three autistic participants. Interviews and analyses were conducted in Swedish, and the data were then translated into English by the authors.

Results: The study identified key insights around four areas: participants' mixed views on the interview guide, the need to accommodate autistic processing styles, the importance of recognizing autistic forms of sociality, and the significance of conducting interviews within an autistic-friendly space that fosters comfort and understanding.

Conclusion: The paper outlines step by step the procedure of conducting group interviews with autistic people. We illustrate ways to capture the possibilities of autistic-friendly interviewing by working with-rather than against-autistic cognition, sociality, and communication styles in interviews with autistic people.

背景:一种神经多样性知情的方法从内部角度认识到自闭症患者的观点和经历,但很少有人关注采用定性方法来解释采访者和参与者的认知、社交和沟通方式的影响。本研究的目的是在小组访谈空间中促进自闭症友好型访谈的发展。方法:采用集体反身性先导研究,探讨自闭访谈者和自闭被试在小组访谈中的经验。该方法遵循五个步骤,从决定在小组面试中使用什么类型的面试问题来测试他们。一位自闭症采访者进行了三次小组访谈,每次访谈两到三名自闭症参与者。访谈和分析是用瑞典语进行的,然后由作者将数据翻译成英语。结果:该研究确定了四个方面的关键见解:参与者对访谈指南的不同看法,适应自闭症处理方式的必要性,认识自闭症社交形式的重要性,以及在自闭症友好的空间中进行访谈的重要性,以促进舒适和理解。结论:本文概述了对自闭症患者进行小组访谈的步骤。我们通过与自闭症患者的认知、社交和沟通方式合作,而不是反对,来说明如何捕捉自闭症友好型面试的可能性。
{"title":"Methodological insights from the inside: developing autistic-friendly interviewing in a group interview space.","authors":"Åsa Hedlund, Maria Eriksson Wester, Pia Edenvik, Cecilia Ingard, Kajsa Isakson, Lisa Kron Sabel, Danielle Uneus, Hanna Bertilsdotter Rosqvist","doi":"10.3389/fpsyt.2025.1659580","DOIUrl":"https://doi.org/10.3389/fpsyt.2025.1659580","url":null,"abstract":"<p><strong>Background: </strong>A neurodiversity-informed approach recognizes the perspectives and experiences of autistic people from an insider perspective, yet little attention has been given to adapting qualitative methods to account for the impact of cognition, sociality, and communication style of both interviewers and participants. The aim of this paper was to contribute to the development of autistic-friendly interviewing in a group interview space.</p><p><strong>Methods: </strong>The paper is a collective reflexive pilot study, exploring experiences of autistic interviewer and autistic participants in group interviews. The method followed five steps, from deciding what type of interview questions to use to test them in the group interviews. An autistic interviewer conducted three group interviews, each with two to three autistic participants. Interviews and analyses were conducted in Swedish, and the data were then translated into English by the authors.</p><p><strong>Results: </strong>The study identified key insights around four areas: participants' mixed views on the interview guide, the need to accommodate autistic processing styles, the importance of recognizing autistic forms of sociality, and the significance of conducting interviews within an autistic-friendly space that fosters comfort and understanding.</p><p><strong>Conclusion: </strong>The paper outlines step by step the procedure of conducting group interviews with autistic people. We illustrate ways to capture the possibilities of autistic-friendly interviewing by working with-rather than against-autistic cognition, sociality, and communication styles in interviews with autistic people.</p>","PeriodicalId":12605,"journal":{"name":"Frontiers in Psychiatry","volume":"16 ","pages":"1659580"},"PeriodicalIF":3.2,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12886361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146165101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1